OPKO Health
OPK
#6317
Rank
โ‚ฌ0.74 B
Marketcap
0,99ย โ‚ฌ
Share price
1.77%
Change (1 day)
-15.81%
Change (1 year)

EPS for OPKO Health (OPK)

EPS in 2025 (TTM): -0,21ย โ‚ฌ

According to OPKO Health 's latest financial reports the company's current EPS (TTM) is -0,21ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -0,06038ย โ‚ฌ an increase over its 2023 EPS that were of -0,22ย โ‚ฌ.

EPS history for OPKO Health from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-0,21ย โ‚ฌ245.87%
2024-0,06038ย โ‚ฌ-72%
2023-0,22ย โ‚ฌ-43.18%
2022-0,38ย โ‚ฌ780%
2021-0,04313ย โ‚ฌ-200%
20200,04313ย โ‚ฌ-109.43%
2019-0,46ย โ‚ฌ96.3%
2018-0,23ย โ‚ฌ-49.06%
2017-0,46ย โ‚ฌ1225%
2016-0,03450ย โ‚ฌ-54.06%
2015-0,07510ย โ‚ฌ-78.23%
2014-0,35ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
7,54ย โ‚ฌ-3,740.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
3,11ย โ‚ฌ-1,603.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
36,69ย โ‚ฌ-17,820.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
3,07ย โ‚ฌ-1,583.33%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
9,80ย โ‚ฌ-4,833.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
3,27ย โ‚ฌ-1,679.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
1,18ย โ‚ฌ-670.83%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Ardelyx
ARDX
-0,20ย โ‚ฌ-4.17%๐Ÿ‡บ๐Ÿ‡ธ USA